OVERVIEW
Balancing the costs and benefits of GLP-1s
White paper
Payer strategies for GLP-1 medications for weight loss
Insight
Read our latest research on GLP-1s

Webinar
Slimming down costs: MFPs and anti-obesity models unpacked
Gain timely insights into the upcoming Medicare Part D Maximum Fair Prices (MFP) for 2026 and 2027. Explore how these changes will impact coverage, access, and the competitive landscape for generics and biosimilars. Plus, discover the transformative power of anti-obesity demonstration models and what they mean for the future of healthcare.

Report
Building a long-range GLP-1 forecast: When could commercial health plans see a plateau?
GLP-1 drugs: We provide a framework for building a long-range forecast to help employers understand how trends may change over time.
White paper
Measuring how GLP-1 medications impact the total cost of care
Approaches to assessing and managing the effects of GLP-1 drugs on health and financial outcomes
Products
Related Milliman products
Cost-saving analysis
Milliman Specialty Pharmacy Insights
Healthcare analytics
MedInsight
Services
